Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 1
2006 2
2007 6
2008 7
2009 7
2010 5
2011 6
2012 8
2013 6
2014 11
2015 17
2016 17
2017 15
2018 15
2019 9
2020 13
2021 12
2022 15
2023 18
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Results by year

Filters applied: . Clear all
Page 1
Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (≥ 5 cm): a multicenter experience over a ten-year period.
Su K, Wang F, Li X, Chi H, Zhang J, He K, Wang Z, Wen L, Song Y, Chen J, Wu Z, Jiang Y, Li H, Gu T, Wang C, Li Y, Liu M, Guo Q, Xu K, Guo L, Han Y. Su K, et al. Among authors: gu t. Front Immunol. 2023 Sep 25;14:1265959. doi: 10.3389/fimmu.2023.1265959. eCollection 2023. Front Immunol. 2023. PMID: 37818373 Free PMC article.
PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis.
Li H, Su K, Guo L, Jiang Y, Xu K, Gu T, Chen J, Wu Z, Wang P, Zhang X, Yan Y, Li S, Wu X, Han L, He K, Wen L, Li B, Han Y. Li H, et al. Among authors: gu t. J Hepatocell Carcinoma. 2023 Jul 29;10:1257-1266. doi: 10.2147/JHC.S415843. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 37538403 Free PMC article.
Controlled-release particulate cytokine adjuvants for cancer therapy.
Egilmez NK, Kilinc MO, Gu T, Conway TF. Egilmez NK, et al. Among authors: gu t. Endocr Metab Immune Disord Drug Targets. 2007 Dec;7(4):266-70. doi: 10.2174/187153007782794335. Endocr Metab Immune Disord Drug Targets. 2007. PMID: 18220947 Review.
Cosmc overexpression enhances malignancies in human colon cancer.
Gao T, Du T, Hu X, Dong X, Li L, Wang Y, Liu J, Liu L, Gu T, Wen T. Gao T, et al. Among authors: gu t. J Cell Mol Med. 2020 Jan;24(1):362-370. doi: 10.1111/jcmm.14740. Epub 2019 Oct 21. J Cell Mol Med. 2020. PMID: 31633299 Free PMC article.
174 results